Clinical Trials

ReCap® Total Hip Resurfacing System

A bone-sparing alternative to total hip replacement surgery.
The Biomet® ReCap® Total Hip Resurfacing System clinical trial is approved by Food and Drug Administration (FDA). The purpose of this research study is to determine the safety and effectiveness of this total resurfacing system, a bone sparing alternative to traditional total hip replacement surgery. Only those patients that meet the pre-defined inclusion/exclusion criteria defined in the FDA approved protocol are eligible to be enrolled in the study.

To be considered for this study, please contact Mary Langhenry, P.T. at 773.250.0480.

4501 North Winchester Avenue • Chicago, Illinois 60640 • Phone: 773.250.1000 • Fax: 773.250.1999